DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
von Minckwitz G, Ponomarova O, Morales S. et al.
Efficacy and safety of biosimilar ABP 980 compared with trastuzumab in HER2 positive early breast cancer.
Ann Oncol 2017;
28 (Suppl. 05) v43-v67 Abstr. 151PD
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.